Quantcast
Last updated on April 17, 2014 at 16:09 EDT

Latest itraconazole Stories

2014-01-08 12:28:08

Presentation to be held at Monday, January 13, 2014 at 10:00 a.m. Pacific Time at the Parc 55 Wyndam in Union Square, San Francisco TAMPA, Fla. and SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that its president and chief executive officer, Mr. Nicholas J. Virca, will present at the...

2013-09-10 16:25:30

Acquires Exclusive U.S. Rights for use of Mayne Pharma's SUBA(TM) Itraconazole for treatment of cancer TAMPA, Fla. and SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCPink: HPPI) (HPPI) announced today that it has signed an exclusive Supply and License Agreement with Mayne Pharma International Pty Ltd (Mayne Pharma), a wholly owned subsidiary of Mayne Pharma Group Limited, an Australian ASX listed company, whereby HPPI will pursue clinical...

2013-08-19 12:24:44

Commences Trading on the OTC Pink Market Under the Symbol "HPPI" TAMPA, Fla. and SAN DIEGO, Aug. 19, 2013 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCPink:HPPI) (HPPI) announced today that it has completed a series of transactions to effectuate the reorganization of Commonwealth Biotechnologies, Inc. (CBTI) and CBTI's exit from its previously announced Chapter 11 proceedings via a Plan of Reorganization that will enable HPPI to operate as a public company. As a new public company,...

2012-07-27 02:27:56

PITTSBURGH, July 27, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Itraconazole Capsules, 100 mg. This product is the generic version of Janssen Pharmaceutical Inc.'s Sporanox(®) and is indicated for the treatment of fungal infections that begin in the lungs, blatsomycosis,...

2009-09-02 06:09:00

BARCELONA, Spain, Sept. 2 /PRNewswire/ -- LIVALO (pitavastatin) may have the potential for fewer drug-drug interactions, versus other statins, as evidenced by a new study that evaluated the effects of itraconazole, an antifungal medication, on the pharmacokinetics of LIVALO in healthy volunteers. The data were presented by Kowa at the European Society of Cardiology (ESC) Congress in Barcelona, Spain. Many statins currently prescribed in the United States, such as atorvastatin and...

2009-07-07 11:25:00

CLEVELAND, July 7 /PRNewswire/ -- TREK Diagnostic Systems, a Magellan Biosciences business and premier provider of diagnostic systems and susceptibility products for microbiology labs, has received clearance from the U.S. Food and Drug Administration (FDA) to include caspofungin in its line of YeastOne susceptibility products. TREK will make the drug available on custom YeastOne formats, allowing clinicians to create the plate that best meets their requirements. The custom format complements...

2009-06-02 07:00:00

CORAL GABLES, Fla., June 2 /PRNewswire/ -- Stiefel Laboratories, Inc. announced the completion and analysis of a pivotal phase III clinical trial for Hyphanox(TM) (itraconazole) tablet. The 200 mg itraconazole tablet formulation was developed using the proprietary Meltrex(R) technology. This trial is the largest randomized controlled clinical study in onychomycosis ever undertaken. The study compared once-daily oral dosing of one 200 mg Hyphanox(TM) tablet to two 100 mg capsules of...

2008-12-29 10:08:37

Some patients with severe asthma who also have allergic sensitivity to certain fungi enjoy great improvements in their quality of life and on other measures after taking an antifungal drug, according to new research from The University of Manchester in England. The findings were reported in the first issue for January of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. "We knew that many people with severe asthma are sensitized to several airborne...

2008-12-05 11:00:00

New Product will Fill Void in the Local Treatment of Oral Candidiasis in Immunosuppressed Patients in China PLAINSBORO, N.J., Dec. 5 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced that the final clinical trial for Tibozole, a locally active antifungal with low dose miconazole in a patented mucoadhesive system, has been initiated in China. This will be the last clinical trial conducted for submission of the New Drug Application (NDA) to the State Food and Drug Administration...

2008-09-23 03:00:09

By Derkach, Yelena Brown, Clarence William Jr The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited to submit your "Clinical Snapshot" to Dermatology Nursing. History A 31-year-old Hispanic male referred to the dermatology clinic presented with painful, bleeding, and pruritic ulcers on his left chin and left medial knee for 6 months. Two months...